Monograph

D07AC13 - Mometasone

Not porphyrinogenic

Rationale

Several references stating non-porphyrinogenicity of glucocorticoids.

Chemical description

Strong glucocorticoid, creme/salve 0.1%, cutaneous solution 0.1%. Used in psoriasis and other steroide sensitive dermatoses. Risk for systemic exposure in application on large areas of the skin. Glucocorticoid: South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: use. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncanâ€™s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe.

IPNet drug reports

Uneventful use reported in 5 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes D07A / D07AC or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames